SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs > Momenta Pharmaceuticals, Inc. (MNTA)

MOMENTA PHARMACEUTICALS, INC. v. AMPHASTAR PHARMACEUTICALS, INC.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
floblu14 Member Profile
Member Level 
Followed By 18
Posts 2,753
Boards Moderated 0
Alias Born 07/20/06
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/14/2017 2:10:28 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/14/2017 2:08:45 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/14/2017 2:06:32 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 11/13/2017 1:54:35 PM
Schedule 13g "Edgar (US Regulatory)" - 11/13/2017 10:06:37 AM
Momenta Pharmaceuticals to Webcast Presentation at the Stifel 2017 Healthcare Conference "GlobeNewswire Inc." - 11/8/2017 8:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/1/2017 9:19:55 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/1/2017 8:12:31 AM
Momenta Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate Update "GlobeNewswire Inc." - 11/1/2017 8:05:00 AM
Momenta and Mylan Report Initial Results from Phase 1 Clinical Trial for M834, a Proposed Biosimilar of ORENCIA® (abatacept)... "GlobeNewswire Inc." - 11/1/2017 8:00:00 AM
Momenta Pharmaceuticals Announces Date of Third Quarter 2017 Financial Results Conference Call and Webcast "GlobeNewswire Inc." - 10/18/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/2/2017 4:25:46 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/2/2017 4:20:33 PM
Momenta Pharmaceuticals Promotes Ganesh V. Kaundinya as Chief Operating Officer and Chief Scientific Officer "GlobeNewswire Inc." - 10/2/2017 4:05:00 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 9/22/2017 12:26:33 PM
Palatin Technologies Announces Appointment of Anthony M. Manning, Ph.D. to Board of Directors "PR Newswire (US)" - 9/12/2017 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/5/2017 3:59:17 PM
Momenta Pharmaceuticals to Webcast Presentation at the 2017 Wells Fargo Healthcare Conference "GlobeNewswire Inc." - 8/30/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/23/2017 4:37:53 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/23/2017 4:32:53 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/23/2017 4:29:45 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/14/2017 3:00:16 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/14/2017 2:57:15 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/14/2017 2:53:17 PM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 8/7/2017 5:13:17 PM
floblu14 Member Level  Wednesday, 12/07/11 09:36:20 AM
Re: None
Post # of 17958 
MOMENTA PHARMACEUTICALS, INC. v. AMPHASTAR PHARMACEUTICALS, INC.

MOMENTA PHARMACEUTICALS, INC., Plaintiff-Appellee, and
SANDOZ, INC., Plaintiff-Appellee,
v.
AMPHASTAR PHARMACEUTICALS, INC., INTERNATIONAL MEDICATION SYSTEMS, LTD., WATSON PHARMACEUTICALS, INC. and WATSON PHARMA, INC., Defendants-Appellants.

Nos. 2012-1062, 2012-xxxx, 2012-xxxx

United States Court of Appeals, Federal Circuit.


December 6, 2011.


This order is nonprecedential

ORDER

Upon consideration of the November 17, 2011 order expediting briefing on the merits of this appeal, the motions to consolidate this appeal with forthcoming appeals, the motion for leave to file a corrected opening brief, the motion for leave to file public and confidential versions of its reply in support of its motion to stay the injunction, and the motions to amend the official caption to add Watson Pharma, Inc.,

IT IS ORDERED THAT:
(1) Oral argument for the merits of the appeal is scheduled to be held at 10 a.m., January 24, 2012, in Courtroom 201. The parties shall notify the clerk in writing of the name of the counsel who will present oral argument no later than January 9, 2012.
(2) The motions to consolidate will be granted and the official caption will be amended to add the appeal numbers from the district court's November 23, 2011 order denying their motion to dissolve the injunction and the district court's December 2, 2011 order denying their emergency motion for relief from the injunction, when those new appeals are docketed by this court.
(3) The motions to reform the caption are granted. Watson Pharma, Inc. is added to the caption. The revised official caption is reflected above.

http://www.leagle.com/xmlResult.aspx?xmldoc=In%20FCO%2020111206163.xml&docbase=CSLWAR3-2007-CURR



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist